Source: LHGDN

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 673
Gene Symbol: BRAF
BRAF
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma 		0.100 GeneticVariation LHGDN Adenocarcinomas with this clinicopathologic phenotype may be worthwhile investigating for BRAF-V600E mutation as more genetically oriented drug therapies emerge. 18636014

2008
Entrez Id: 673
Gene Symbol: BRAF
BRAF
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma 		0.100 Biomarker LHGDN BRAF activation initiates but does not maintain invasive prostate adenocarcinoma. 19079609

2008
Entrez Id: 673
Gene Symbol: BRAF
BRAF
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma 		0.100 PosttranslationalModification LHGDN RASSF1A methylation was found in 27 adenocarcinomas (23.5%) and inversely correlated with KRAS and/or BRAF mutation (p=0.002) in cervical adenocarcinoma. 17360030

2007
Entrez Id: 673
Gene Symbol: BRAF
BRAF
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma 		0.100 GeneticVariation LHGDN Prostate adenocarcinomas with a BRAF mutation tended to show higher preoperative serum PSA levels, Gleason scores and tumor stages than prostate adenocarcinomas with a KRAS mutation. 16721785

2006
Entrez Id: 673
Gene Symbol: BRAF
BRAF
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma 		0.100 GeneticVariation LHGDN Activating BRAF mutations were identified in 2/19 Barrett's adenocarcinomas (11%) and in 1/27 HGIN (4%). 14724583

2004
Entrez Id: 673
Gene Symbol: BRAF
BRAF
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma 		0.100 GeneticVariation LHGDN Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas. 14688025

2004
Entrez Id: 673
Gene Symbol: BRAF
BRAF
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma 		0.100 GeneticVariation LHGDN BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets. 14507635

2003